HeartSciences Inc.
HSCS · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $2 | $0 | $0 | $0 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | -$1 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 27.3% | -56.3% | – | – |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | -1,282.5% | 60% | -661.9% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -84,282.8% | -96,822.7% | -43,269.4% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -97,179.4% | -108,157.6% | -48,145.5% | – |
| EPS Diluted | -0.85 | -1.58 | -1.88 | -2.57 |
| % Growth | 46.2% | 16% | 26.8% | – |
| Operating Cash Flow | -$2 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$2 | -$0 | -$0 | -$0 |